BioLineRx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioLineRx and other ETFs, options, and stocks.About BLRX
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors.
CEOPhilip Adam Serlin
CEOPhilip Adam Serlin
Employees24
Employees24
HeadquartersModi'in, HaMerkaz
HeadquartersModi'in, HaMerkaz
Founded2003
Founded2003
Employees24
Employees24
BLRX Key Statistics
Market cap10.27M
Market cap10.27M
Price-Earnings ratio-13.09
Price-Earnings ratio-13.09
Dividend yield—
Dividend yield—
Average volume20.58K
Average volume20.58K
High today$2.40
High today$2.40
Low today$2.25
Low today$2.25
Open price$2.40
Open price$2.40
Volume16.26K
Volume16.26K
52 Week high$7.77
52 Week high$7.77
52 Week low$2.25
52 Week low$2.25
BLRX News
TipRanks 3d
BioLineRx: Advancing GLIX1 and Motixafortide Pipeline with Strengthened IP and Legal Position Underpinning Buy Rating and $12 TargetJustin Walsh, an analyst from JonesTrading, reiterated the Buy rating on Bioline RX Ltd Sponsored ADR. The associated price target is $12.00. Justin Walsh has...
TipRanks 4d
BioLineRx Launches First-in-Human Trial of GLIX1 for GlioblastomaAn update from Bioline RX Ltd Sponsored ADR ( (BLRX) ) is now available. BioLineRx Ltd., a clinical-stage biopharmaceutical company specializing in oncology an...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.